0001209191-22-051980.txt : 20221003 0001209191-22-051980.hdr.sgml : 20221003 20221003194814 ACCESSION NUMBER: 0001209191-22-051980 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220627 FILED AS OF DATE: 20221003 DATE AS OF CHANGE: 20221003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ALLEN SIMON CENTRAL INDEX KEY: 0001606829 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40388 FILM NUMBER: 221289252 MAIL ADDRESS: STREET 1: C/O AMBRX, INC. STREET 2: 10975 N. TORREY PINES RD. CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Anebulo Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001815974 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 851170950 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 1415 RANCH ROAD 629 SOUTH, SUITE 201 CITY: LAKEWAY STATE: TX ZIP: 78734 BUSINESS PHONE: 737 203 5270 MAIL ADDRESS: STREET 1: 1415 RANCH ROAD 629 SOUTH, SUITE 201 CITY: LAKEWAY STATE: TX ZIP: 78734 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-06-27 0 0001815974 Anebulo Pharmaceuticals, Inc. ANEB 0001606829 ALLEN SIMON C/O ANEBULO PHARMACEUTICALS, INC. 1415 RANCH ROAD 620 SOUTH, SUITE 201 LAKEWAY TX 78734 1 1 0 0 Chief Executive Officer Stock Option (right to buy) 7.02 2022-06-27 4 A 0 77457 0.00 A 2027-07-31 Common Stock 77457 77457 D 4,841 shares vest immediately. The remainder of the shares vest ratably in 15 quarterly installments (4,841.06 shares each Quarter) from July 1, 2022 through January 1, 2026. All shares subject to the option will vest immediately upon the satisfaction of certain performance conditions that were established at the time of the Compensation Committee's approval of the option on June 23, 2022. /s/ James R. Merchant, Attorney-in-Fact 2022-10-03